Clinical Trials Logo

HIV/AIDS clinical trials

View clinical trials related to HIV/AIDS.

Filter by:

NCT ID: NCT04048382 Completed - HIV/AIDS Clinical Trials

Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate)

Start date: August 5, 2019
Phase: N/A
Study type: Interventional

This study aims to help young Latino gay and bisexual men access sexual health information, including PrEP. Participants will be randomly assigned to either the patient navigation or the usual care condition and followed for 6 months. The study will recruit self-identified Latino men between the ages of 18 and 29 who also identify as gay, bisexual, and/or have sex with other men, and report CDC defined HIV risk behaviors.

NCT ID: NCT04045652 Recruiting - HIV Infections Clinical Trials

Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women

Start date: November 18, 2021
Phase:
Study type: Observational

This study will utilize a longitudinal study design to better understand the natural history of oncogenic Human Papillomavirus (HPV) infections in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected Kenyan women, including the potentially modifiable (and non-modifiable) factors that are associated with progression of oncogenic HPV infection to clinical disease, including cervical cancer.

NCT ID: NCT04045184 Recruiting - Diabetes Clinical Trials

Food Assistance, Diabetes, and HIV

BFED
Start date: October 20, 2018
Phase:
Study type: Observational

Diabetes prevalence is increasing among people living with HIV (PLWH), yet blood glucose control is less successful in this population who are also often food insecure. Food assistance programs often provide nutrient-poor foods. This proposal asses the feasibility of monitoring diabetes-related health outcomes among food insecure PLWH who are receiving food boxes higher in dietary protein and fiber and lower in simple carbohydrates.

NCT ID: NCT04044235 Recruiting - HIV/AIDS Clinical Trials

Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young Women

Start date: June 25, 2019
Phase: N/A
Study type: Interventional

To provide preliminary evidence about feasibility and acceptability of delivering PrEP to AGYW identified as potentially at high risk of HIV infection in Lilongwe city communities and two public facilities in Lilongwe, Malawi. The primary objective of the study is to assess the feasibility, acceptability, tolerability and cost of delivering PrEP among high-risk AGYW aged 18-24 years and healthcare providers in urban Lilongwe. Secondary objectives are (i) to assess the program's ability to enroll and retain a PrEP cohort for one year and (ii) measure the incidence of HIV infection among high risk AGYW in urban Lilongwe among women who decline to enroll in the PrEP study (these will be offered enrollment in the HIV incidence study).

NCT ID: NCT04038060 Completed - HIV/AIDS Clinical Trials

The PrEP (Pre-exposure Prophylaxis) SMART Study

Start date: May 16, 2019
Phase: N/A
Study type: Interventional

The PrEP SMART study is testing a stepped model of scalable adherence support strategies in South African young women who initiate PrEP using a SMART (sequential multiple assignment randomized trial) design.

NCT ID: NCT04035759 Completed - HIV/AIDS Clinical Trials

Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy

Start date: October 16, 2019
Phase: Phase 1
Study type: Interventional

This study assesses the feasibility and acceptability of the APPEAL program, a 3-session intervention designed to promote positive affect among men and women living with HIV infection. Forty participants will be randomly assigned to receive the APPEAL program, and another 40 will receive standard of care. All participants will complete self-reported assessments at baseline and at 3 and 6 months, and will have their HIV antiretroviral medication adherence monitored as part of study participation.

NCT ID: NCT04033718 Recruiting - Tuberculosis Clinical Trials

Inpatient Package to Reduce HIV and AIDS-related Death in Zambia

IPADZ
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Early post-discharge mortality is high among HIV-infected Zambians admitted to the hospital. Likely this is in part due to missed opportunities to identify lethal coinfections and optimize HIV care during admission (and before discharge). In this study the investigators will develop and pilot a new approach to inpatient HIV care that follows international guidelines for management of advanced HIV disease.

NCT ID: NCT04030520 Completed - HIV/AIDS Clinical Trials

Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda

POPPi
Start date: July 8, 2019
Phase: N/A
Study type: Interventional

The main aim is to develop and assess an intervention to enhance initiation and adherence to PrEP among HIV negative young women of high risk (YWHR). The specific aims are (1) To conduct formative research to enhance our understanding of the dynamics of the social and sexual networks, and context of young HIV-uninfected women (aged 15-24) engaged in high risk sexual behavior in Kampala, Uganda (2) Document barriers and opportunities for PrEP uptake and adherence as well as repeat HIV testing by self test; (3) To develop and test a socially and culturally acceptable and feasible prevention intervention on uptake and adherence to PrEP and HIV self-testing for young women at high risk for HIV.

NCT ID: NCT04027153 Completed - HIV/AIDS Clinical Trials

The Deliver Health Study

Start date: October 7, 2019
Phase: N/A
Study type: Interventional

The investigators hypothesize that routing algorithm based ART delivery will be acceptable, efficient and improve health outcomes, specifically through meeting client needs, retaining HIV-positive persons in care, and achieving high ART resupply and viral suppression. They also hypothesize that a fee for home delivery will improve retention and viral suppression among persons willing to pay a fee for ART delivery. The investigators propose to test ART delivery using routing science and fee for home delivery as strategies that could be scaled-up to sustain lifelong ART.

NCT ID: NCT04025463 Completed - HIV/AIDS Clinical Trials

Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV

HHMB
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

"Healing our Minds and Bodies" (HHMB) uses a a hybrid type II effectiveness/implementation study design to increase both patient and organizational readiness to address trauma and CVD risk among African American and Latino persons living with HIV or AIDS (PLWHIV).